Canadian Urological Association Annual Meeting Coverage
Study shows a significantly better 5-year cancer-specific survival rate compared with radical cystectomy.
Use of the drug reduced the risk of recurrence and cancer-related mortality in diabetic patients undergoing radical cystectomy.
Transient rises in PSA after radiotherapy may be due to late damage to healthy prostatic tissue, evidence suggests.
Increased long-term risk observed in men on active surveillance.
Complication and retreatment rates are higher than in normal-weight patients, Canadian study finds.
It has a sensitivity of 92% and a specificity of 100%.
Technological advancements in ureteroscopes are among the reasons.
Aspirin use was associated with a twofold higher odds having prostate cancer detected.
Active surveillance for low-risk prostate cancer is associated with a low risk for progression and very good 10-year cancer-specific survival.
Findings emerged from a study of BPH patients with prostates weighing 200 grams or more.
TORONTO—Patients with muscle-invasive bladder cancer whose tumors express cyclooxygenase-2 (COX-2) appear to have improved disease-specific survival.
Stone-free rates and the incidence of post-op complications are similar to those of the nonobese
TORONTO—Patients with horseshoe kidneys appear to have lower single-treatment success and stone-free rates after shock-wave lithotripsy (SWL) than patients with normal kidneys, data suggest.
Prostate cancer patients who use statins may be at lower risk of PSA recurrence after radical prostatectomy (RP) compared with those who do not use the medications, according to investigators.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)